Spots Global Cancer Trial Database for thyroid cancer
Every month we try and update this database with for thyroid cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Thyroid Cancer Among Chornobyl Clean-up Workers in Ukraine: Pilot Study | NCT01265381 | Thyroid Cancer | 18 Years - 65 Years | National Institutes of Health Clinical Center (CC) | ||
| Predictive Value of microRNA in Thyroid Cytologies of Undetermined Type | NCT04285476 | Thyroid Cancer | Signature of mi... | 18 Years - | Institut du Cancer de Montpellier - Val d'Aurelle | |
| Role of NGS-based ThyroSeq Panel in Cancer Diagnosis in Thyroid Nodules | NCT02352766 | Thyroid Nodule | 18 Years - | University of Pittsburgh | ||
| Dexamethasone Reduces Postoperative Emesis by Decreasing PGF2α and LTC4 Levels | NCT01811199 | Thyroid Cancer Breast Cancer | 18 Years - 65 Years | Marmara University | ||
| Anxiety & Depression in Thyroid Cancer Patients | NCT06269731 | Thyroid Cancer | Hamilton depres... | 18 Years - 90 Years | Assiut University | |
| NGS-based Thyroscan Genomic Classifier in the Diagnosis of Thyroid Nodules | NCT05025046 | Thyroid Nodule Thyroid Cancer | Thyroscan | 18 Years - | Rigen Biotech | |
| Validation of the Diagnostic Accuracy of the Electronic Nose in the Detection of Thyroid Cancer | NCT04883294 | Thyroid Neoplas... | Electronic Nose | 18 Years - | Maastricht University Medical Center | |
| Lesion Dosimetry With 124-Iodine in Metastatic Thyroid Carcinoma | NCT00673010 | Thyroid Cancer | 131 I-iodine (1... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Intra-operative Rapid Identification of Lymph Node and Parathyroid | NCT03268785 | Thyroid Cancer Parathyroid; Ab... Hypocalcemia Hypoparathyroid... | Intraoperative ... | 18 Years - 60 Years | Xijing Hospital | |
| Khon Kaen University's Thyroidectomy Registry | NCT03031639 | Thyroid Nodule Thyroid Neoplas... Thyroid Cancer | Endoscopic appr... | - | Khon Kaen University | |
| Combination of Temsirolimus and Sorafenib in the Treatment of Radioactive Iodine Refractory Thyroid Cancer | NCT01025453 | Thyroid Cancer | Temsirolimus an... | 21 Years - | Memorial Sloan Kettering Cancer Center | |
| Dental Safety Profile of High-Dose Radioiodine Therapy | NCT00439478 | Thyroid Cancer | Radioiodine | - | University Hospital, Basel, Switzerland | |
| Clinical Prediction Thyroid Cancer With Thyroid Ultrasonography | NCT03294005 | Thyroid Cancer | Thyroid ultraso... | 20 Years - | China Medical University Hospital | |
| Assess Vitamin D Levels in Those With & Without Thyroid Cancer | NCT00719615 | Thyroid Cancer | 19 Years - | University of Nebraska | ||
| XP-102 and XP-102 in Combination With Trametinib in Advanced Solid Tumor Patients With a BRAF V600 Mutation | NCT05275374 | Cancer BRAF V600 Mutat... Melanoma Colorectal Canc... Thyroid Cancer Nonsmall Cell L... | XP-102 Trametinib | 18 Years - | Xynomic Pharmaceuticals, Inc. | |
| Clinical Trial in RAI-Refractory Thyroid Carcinoma Evaluating BRAF & MEK Blockade for Re-differentiation Therapy | NCT04554680 | Thyroid Cancer | dabrafenib and ... | 21 Years - 99 Years | National University Hospital, Singapore | |
| Fosbretabulin or Placebo in Combination With Carboplatin/Paclitaxel in Anaplastic Thyroid Cancer | NCT01701349 | Anaplastic Thyr... | Fosbretabulin +... Placebo + pacli... | 18 Years - | Mateon Therapeutics | |
| Hashimotos Thyroiditis and Thyroid Cancer | NCT01428167 | Thyroid Cancer Hashimotos Thyr... | 18 Years - 80 Years | The University of Texas Medical Branch, Galveston | ||
| Effect of Reversed Tracking Method for Identification of EBSLN in Thyroid Surgery | NCT03680222 | Thyroid Cancer Recurrent Laryn... | Reversed Tracki... | 18 Years - 60 Years | Fujian Medical University | |
| Impact of Papillary Microcarcinoma Terminology on Patients Treatment Preferences: a Cross Sectional Survey | NCT02726282 | Thyroid Cancer | 18 Years - | Mayo Clinic | ||
| ESTIMation of the ABiLity of Prophylactic Central Compartment Neck Dissection to Modify Outcomes in Low-risk Differentiated Thyroid Cancer | NCT03570021 | Thyroid Cancer | total thyroidec... total thyroidec... | 18 Years - | Gustave Roussy, Cancer Campus, Grand Paris | |
| Thyroid Cancer Among Chornobyl Clean-up Workers in Ukraine: Pilot Study | NCT01265381 | Thyroid Cancer | 18 Years - 65 Years | National Institutes of Health Clinical Center (CC) | ||
| The Incidence of Breast and Other Cancers Among Female Flight Attendants | NCT00342407 | Thyroid Cancer Breast Cancer Non-Melanoma Sk... Melanoma | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) | ||
| Treatment for Patients With Metastatic Thyroid Cancer | NCT00176748 | Thyroid Cancer | AG 6013736 | 18 Years - | University of Michigan Rogel Cancer Center | |
| Khon Kaen University's Thyroidectomy Registry | NCT03031639 | Thyroid Nodule Thyroid Neoplas... Thyroid Cancer | Endoscopic appr... | - | Khon Kaen University | |
| Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department | NCT04104529 | Thyroid Cancer Prostate Cancer Neuroendocrine ... | Biological coll... tumor collectio... | 18 Years - | Institut du Cancer de Montpellier - Val d'Aurelle | |
| Parathyroid Vascularization During Total Thyroidectomy Using Indocyanine Green Angiography | NCT05328076 | Thyroid Thyroid Cancer Hypoparathyroid... Vascularization | Indocyanine gre... SPY Portable Ha... | 18 Years - | IRCCS San Raffaele | |
| Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma | NCT00413075 | Solid Tumor Lymphoma | oral belinostat | 18 Years - | Valerio Therapeutics | |
| A Multicenter Trial of PLA vs. Surgery for Treating PTMC | NCT03377829 | Thyroid Cancer Treatment Relat... | PLA Thyroid Surgery | 18 Years - | Ruijin Hospital | |
| An Easy Sonographic Scoring System for Predicting Malignant Thyroid Nodules | NCT01307761 | Thyroid Cancer | 18 Years - 90 Years | Far Eastern Memorial Hospital | ||
| The Ultracyt Study - is EU-TIRADS Useful in Selecting Nodules for Fine Needle Aspiration Cytology? | NCT05583097 | Thyroid Cancer Thyroid Nodule | Non-selective c... | 18 Years - | Vastra Gotaland Region | |
| Long Non Coding RNA HOTAIR and Midkine as Biomarkers in Thyroid Cancer | NCT03469544 | Thyroid Cancer | complete blood ... | 20 Years - | Assiut University | |
| Effects of Thyroid Hormone Withdrawal on Metabolic Parameters During Radioactive Iodine Therapy in Thyroid Cancer | NCT01744769 | Hypothyroidism | 18 Years - 80 Years | Konkuk University Medical Center | ||
| PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer | NCT04544111 | Thyroid Cancer Thyroid Cancer,... Papillary Thyro... Follicular Thyr... Hurthle Cell Tu... Poorly Differen... Hurthle Cell Th... | Trametinib Dabrafenib PDR001 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Sorafenib as Adjuvant to Radioiodine Therapy in Non-Medullary Thyroid Carcinoma | NCT00887107 | Thyroid Cancer | Sorafenib (nexa... | 18 Years - 80 Years | Leiden University Medical Center | |
| Impact of BRAFV600E Intratumor Heterogeneity in Thyroid Cancer Treated With Tyrosine Kinase Inhibitors | NCT01700699 | Differentiated ... | - | University of Salerno | ||
| Thyroid Cancer in United Arab Emirates | NCT04763122 | Thyroid Cancer | not applicable ... | - | Tawam Hospital | |
| A Study To Assess ZD6474 (ZACTIMA™) Monotherapy In Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer | NCT00358956 | Thyroid Cancer | ZD6474 (vandeta... | 18 Years - | Sanofi | |
| Protective Effect of Intraoperative Parathyroid Gland Auxiliary Recognition System in Thyroid Malignant Tumor Operation | NCT04560426 | Parathyroid Intraoperative ... Thyroid Cancer | Intraoperative ... | 20 Years - 50 Years | Fudan University | |
| Artificial Tears to Prevent Nasolacrimal Duct Obstruction in Patients Treated With Radioactive Iodine for Thyroid Cancer | NCT05999630 | Nasolacrimal Du... Thyroid Cancer | Artificial Tear... | 18 Years - | Vanderbilt University Medical Center | |
| Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer | NCT00507429 | Anaplastic Thyr... | CA4P paclitaxel carboplatin | 18 Years - | Mateon Therapeutics | |
| Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors | NCT02988817 | Ovarian Cancer Cervical Cancer Endometrial Can... Non Small Cell ... Thyroid Cancer Melanoma Sarcoma Solid Tumors | Enapotamab vedo... | 18 Years - | Genmab | |
| Differentiated Thyroid Cancer Patients Treated With Different Doses of Radioactive Iodine. | NCT06134830 | Thyroid Cancer | RAI | - | Assiut University | |
| Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma | NCT06087068 | Thyroid Cancer Surgery Recurrence | Thyroxine | 18 Months - 70 Years | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
| GETNE Registration of Thyroid Cancer | NCT03765333 | Thyroid Cancer | 18 Years - | Grupo Espanol de Tumores Neuroendocrinos | ||
| A Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 Milligram (mg) Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile | NCT02702388 | Thyroid Cancer | Lenvatinib Lenvatinib matc... | 18 Years - | Eisai Inc. | |
| Assessment of CA 19-9 in Patients' With Thyroid Malignancies | NCT05124938 | Thyroid Cancer | Laboratory inve... | 1 Year - 80 Years | Sohag University | |
| Active Surveillance for Low-risk Papillary Thyroid Carcinoma | NCT06261190 | Thyroid Cancer Papillary Thyro... | 18 Years - | National Cancer Center, Korea | ||
| Predicting Prognosis and Recurrence of Thyroid Cancer Via New Biomarkers, Urinary Exosomal Thyroglobulin and Galectin-3 | NCT03488134 | Thyroid Cancer | 20 Years - 80 Years | National Taiwan University Hospital | ||
| TRAIL Study: Feasibility and Pilot | NCT06220656 | Thyroid Nodule Thyroid Neoplas... Thyroid Cancer | Biopsy Active Monitori... | 18 Years - | Dartmouth-Hitchcock Medical Center | |
| Radioiodine-avid Bone Metastases From Thyroid Cancer Without Structural Abnormality | NCT04141306 | Bone Metastases Thyroid Cancer | Administrative ... Clinical data Histological da... Imaging data Biological data Further treatme... | 18 Years - 80 Years | Hospices Civils de Lyon | |
| Study of External Beam Radiotherapy to Thyroid Carcinoma | NCT01173289 | Thyroid Cancer | External Beam R... | 18 Years - | National Cancer Center, Korea | |
| Digoxin for the Reinduction of Radioiodine Uptake in Metastatic or Locally Advanced Non-medullary Thyroid Carcinoma | NCT05507775 | Non-Medullary T... | Digoxin tablet | 18 Years - | Radboud University Medical Center | |
| A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Advanced Thyroid Cancer Patients (TOPICS-THYROID) | NCT05541380 | Thyroid Cancer | A Taiwanese Onc... | 20 Years - | National Health Research Institutes, Taiwan | |
| Levothyroxine Replacement With Liquid Gel Capsules vs Tablets Post-thyroidectomy | NCT02946918 | Thyroid Cancer Postsurgical Hy... | Levothyroxine | 18 Years - | University of Texas Southwestern Medical Center | |
| A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors | NCT06336148 | Solid Tumor | ACTM-838 | 18 Years - | Actym Therapeutics, Inc. | |
| Decision Making and Psychological Outcomes in Low-Risk Papillary Thyroid Cancer | NCT03300284 | Thyroid Cancer | Questionnaires | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Active Surveillance for Low-risk Papillary Thyroid Carcinoma | NCT06261190 | Thyroid Cancer Papillary Thyro... | 18 Years - | National Cancer Center, Korea | ||
| Camrelizumab and Apatinib for Neoadjuvant Therapy in Thyroid Cancer | NCT04612894 | Thyroid Cancer | Camrelizumab an... surgery core needle bio... | 14 Years - | Fudan University | |
| Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival & Frozen Tissue Sample | NCT00568438 | Breast Cancer Stomach Neoplas... Salivary Gland ... Thyroid Cancer | 18 Years - | Stanford University | ||
| Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Thyroid Cancer | NCT04948437 | Thyroid Cancer Papillary Thyro... Follicular Thyr... | 20 Years - 80 Years | National Taiwan University Hospital | ||
| Active Surveillance and Surgery Outcomes in Low Risk Papillary Thyroid Cancer | NCT04624477 | Papillary Thyro... Papillary Thyro... Papillary Micro... | 18 Years - | University Health Network, Toronto | ||
| Tri-modal Imaging Instrument for Thyroid Cancer | NCT02758158 | Thyroid Neoplas... Thyroid Cancer Thyroid Nodule | Tri-modal imagi... | 18 Years - | University Health Network, Toronto | |
| Expanded Access Program With Lenvatinib for the Treatment of Differentiated Thyroid Cancer in Brazil | NCT03533361 | Thyroid Cancer | Lenvatinib | 18 Years - | Eisai Inc. | |
| BRAF V600E and Redifferentiation Therapy in Radioiodine-refractory Papillary Thyroid Cancer | NCT03363347 | Thyroid Cancer | Redifferentiati... | 24 Years - 69 Years | Heidelberg University | |
| Treatment of Papillary Thyroid Carcinoma With Radiofrequency Ablation | NCT04129411 | Papillary Thyro... Papillary Thyro... | RFA | 18 Years - 85 Years | Mayo Clinic | |
| Enhancing Radioiodine Incorporation Into BRAF Mutant Thyroid Cancers With the Combination of Vemurafenib and KTN3379 | NCT02456701 | Thyroid Cancer | KTN3379 vemurafenib | 18 Years - | Celldex Therapeutics | |
| Minimizing Narcotic Analgesics After Endocrine Surgery | NCT03469310 | Thyroid Cancer Thyroid Nodule Thyroid Neoplas... Thyroid Goitre Thyroid Disease... Parathyroid Dis... Parathyroid Ade... Parathyroid Hyp... | Acetaminophen 5... Tylenol #3 Oral... Tramadol | 18 Years - | DHR Health Institute for Research and Development | |
| Efficacy and Tolerability of ZD6474 in Patients With Thyroid Cancer | NCT00098345 | Thyroid Cancer | ZD6474 (vandeta... | 18 Years - 130 Years | Sanofi | |
| Circulating Biomarkers to Identify Thyroid Cancer | NCT04594720 | Thyroid Cancer Thyroid Cancer,... Benign Thyroid ... | Identification ... Validation grou... | 20 Years - 100 Years | Chang Gung Memorial Hospital | |
| A Prospective, Open-label, Multicenter, Randomized Controlled Phase III Study of Prophylactic Central Neck Dissection in Low-risk Papillary Thyroid Cancer | NCT06082180 | Thyroid Cancer Recurrence | prophylactic ce... | 18 Years - 70 Years | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
| Study on Application of Suturing Parathyroid Markers in Thyroid Cancer Surgery | NCT03514251 | Thyroid Cancer Hypoparathyroid... Marker; Structu... Complication of... Parathyroid Fun... | The suture mark... | 18 Years - 70 Years | Fujian Medical University | |
| A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy | NCT01624220 | Spinal Tumor | Spinal SBRT (St... Spinal SBRT (Hi... Gold Seed Impla... Questionnaires | 18 Years - | M.D. Anderson Cancer Center | |
| Predictive Factors of Lymph Node Metastasis in Patients With Papillary Microcarcinoma of the Thyroid | NCT04274829 | Thyroid Cancer Lymph Node Meta... | Thyroidecomt an... | - | University of Cagliari | |
| Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations | NCT04521686 | Cholangiocarcin... Chondrosarcoma Glioma Any Solid Tumor | LY3410738 Gemcitabine Cisplatin Durvalumab | 18 Years - | Eli Lilly and Company | |
| Safety and Efficacy Study of Ultrasonic Coagulation Device and Bipolar Energy Sealing System | NCT01565486 | Thyroid Cancer | Ultrasonic coag... bipolar energy ... | 20 Years - 80 Years | Seoul St. Mary's Hospital | |
| Nivolumab Plus Ipilimumab in Thyroid Cancer | NCT03246958 | Thyroid Cancer | Nivolumab Ipilimumab | 18 Years - | Dana-Farber Cancer Institute | |
| Evaluation of Metformin Effect on the Fertility of Women Treated With 131I for Thyroid Cancer | NCT05468554 | Thyroid Cancer | metformin Radioactive iod... | 18 Years - 45 Years | Medical University of Bialystok | |
| Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors | NCT00413322 | Tumor | belinostat 5-Fluorouracil ... | 18 Years - | Valerio Therapeutics | |
| A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001) | NCT03157128 | Non-Small Cell ... Medullary Thyro... Colon Cancer Any Solid Tumor | LOXO-292 | 12 Years - | Eli Lilly and Company |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
